Is Neoadjuvant Chemoradiotherapy Beneficial for Patients With Pancreatic Cancer?

被引:1
|
作者
Mroczkowski, Pawel [1 ,2 ,3 ]
Zajdel, Radoslaw [4 ]
机构
[1] Ruhr Univ Bochum, Dept Surg, Univ Hosp, Knappschaftskrankenhaus Bochum, Bochum, Germany
[2] Otto von Guericke Univ, An Ist Qual Assurance Operat Med Ltd, Magdeburg, Germany
[3] Med Univ Lodz, Dept Gen & Colorectal Surg, Lodz, Poland
[4] Med Univ Lodz, Dept Med Informat & Stat, Lodz, Poland
关键词
D O I
10.1200/JCO.22.00454
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3347 / 3348
页数:2
相关论文
共 50 条
  • [1] Neoadjuvant Chemoradiotherapy is effective in Patients with Pancreatic Cancer
    Di Lellis, Maddalena Angela
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (08): : 1177 - 1177
  • [2] Is neoadjuvant chemoradiotherapy for pancreatic cancer beneficial: A systematic review and meta-analysis
    Luo, Wenhao
    Wang, Yawen
    Tao, Yinjie
    Zhang, Taiping
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Neoadjuvant chemoradiotherapy for resectable pancreatic cancer
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05): : 392 - 392
  • [4] Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer
    Sho, Masayuki
    Akahori, Takahiro
    Tanaka, Toshihiro
    Kinoshita, Shoichi
    Nagai, Minako
    Nishiwada, Satoshi
    Tamamoto, Tetsuro
    Nishiofuku, Hideyuki
    Ohbayashi, Chiho
    Hasegawa, Masatoshi
    Kichikawa, Kimihiko
    Nakajima, Yoshiyuki
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2015, 400 (04) : 477 - 485
  • [5] The role of neoadjuvant chemoradiotherapy in resectable pancreatic cancer
    Kim, H. J.
    Bang, S.
    Park, S. W.
    Chung, J. B.
    Song, S. Y.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A138 - A138
  • [6] Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer
    Masayuki Sho
    Takahiro Akahori
    Toshihiro Tanaka
    Shoichi Kinoshita
    Minako Nagai
    Satoshi Nishiwada
    Tetsuro Tamamoto
    Hideyuki Nishiofuku
    Chiho Ohbayashi
    Masatoshi Hasegawa
    Kimihiko Kichikawa
    Yoshiyuki Nakajima
    [J]. Langenbeck's Archives of Surgery, 2015, 400 : 477 - 485
  • [7] Is Robotic Surgery Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy?
    Jung Kyong Shin
    Hee Cheol Kim
    Woo Yong Lee
    Seong Hyeon Yun
    Yong Beom Cho
    Jung Wook Huh
    Yoon Ah Park
    [J]. Annals of Surgical Oncology, 2024, 31 : 3203 - 3211
  • [8] Is Robotic Surgery Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy?
    Shin, Jung Kyong
    Kim, Hee Cheol
    Lee, Woo Yong
    Yun, Seong Hyeon
    Cho, Yong Beom
    Huh, Jung Wook
    Park, Yoon Ah
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (5) : 3203 - 3211
  • [9] Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer
    Cho, In Rae
    Chung, Moon Jae
    Bang, Seungmin
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    Seong, Jinsil
    Hwang, Ho Kyoung
    Kang, Chang Moo
    Lee, Woo Jung
    Park, Jeong Youp
    [J]. PANCREATOLOGY, 2013, 13 (05) : 539 - 543
  • [10] Local Immunological Effect of Neoadjuvant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Cancer
    Murakami, T.
    Mori, R.
    Matsuyama, R.
    Homma, Y.
    Nakazawa, M.
    Tanaka, Y.
    Miyake, K.
    Sawada, Y.
    Oota, Y.
    Hiroshima, Y.
    Kumamoto, T.
    Ueda, M.
    Takeda, K.
    Ichikawa, Y.
    Tanaka, K.
    Endo, I.
    [J]. PANCREAS, 2014, 43 (08) : 1394 - 1394